Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves ‘Spravato’ Nasal Spray
Can a Nasal Spray Really Help Treat Depression? Here's What to Know About Spravato
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
Spravato Approved as Monotherapy for Treatment-Resistant Depression
The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, placebo-controlled, phase 4 TRD4005 trial.
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.
FiercePharma
5d
Johnson & Johnson's Spravato gains FDA nod to be used as a monotherapy
Already on its way to becoming a blockbuster drug, Johnson & Johnson’s Spravato has received another potential boost as the ...
BioSpace
4d
J&J’s Spravato Makes Headway in Tough Depression Space With Monotherapy Approval
Esketamine, the active ingredient in Spravato, is a non-selective, non-competitive antagonist of the NMDA receptor, a known ...
2d
Does Medicare cover ketamine infusions for mental health conditions?
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Los Angeles wildfire updates
Colombia tariffs paused
Graham on Jan. 6 pardons
DOJ drops case
38 hurt on United flight
US lifts bomb restrictions
Sentenced to 17+ years
Shifts view on COVID origins
IA immigration law blocked
Chiefs beat Bills
Win sixth ice dance title
Emil Bove visits Chicago
‘Flight Risk’ tops box office
Smuggling deaths guilty plea
Eagles defeat Commanders
‘Walk It Out’ rapper dies
Israel, Lebanon extend truce
Proposed ban withdrawn
Hack impacted 190M
Assault trial begins
Wins US figure skating title
NK tested cruise missiles?
PETA activists arrested
Escaped monkeys captured
Wins first Grand Slam title
ISR to get 2K-pound bombs
Indicted for insurrection
Confirmed to lead Pentagon
Nets retire No. 15 jersey
Recalls over 80,000 SUVs
Related topics
depression
FDA
United States
ketamine
Johnson & Johnson
Feedback